Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.
What a garbage stock
Don’t even think anyone will partner with this pos. Why would you need to find a partnership if your confident with the productivity?
Still don’t understand why it is dropping. They announce good news instead of negative but the number are dropping. Can anyone tell me what is going on?